CSL’s (ASX: CSL) differentiated product portfolio drives earnings growth, market outperformance
CSL Limited (ASX: CSL) is involved in researching, developing, manufacturing, marketing, and distributing biopharmaceutical products and vaccines. It provides innovative life-saving medications across 100 countries. In the first half of the financial year 2024 (1HFY24), revenue of CSL increased by 12% YoY to USD …
Team Kalkine |
10 Apr 2024| Read Time : 10 Mins